Shohei Mishima
- Pharmacology top 10%
- Neurology top 10%
- Epidemiology
- Cellular and Molecular Neuroscience
- Clinical Biochemistry top 10%
- Co-authors
- Michihiro FujiwaraKazuhide HayakawaKenichi MishimaKatsunori IwasakiNobuaki EgashiraMai HazekawaKensuke OritoMasayuki Fujioka
- Topics
- Cannabis and Cannabinoid Research (4 papers)Sleep and Wakefulness Research (3 papers)Lung Cancer Treatments and Mutations (3 papers)
- Partner nations
- JapanAustriaUnited States
In The Last Decade
Shohei Mishima
12 papers receiving 324 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 114
- Neurology 106
- Epidemiology 74
- Cellular and Molecular Neuroscience 70
- Clinical Biochemistry 51
Countries citing papers authored by Shohei Mishima
This map shows the geographic impact of Shohei Mishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shohei Mishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shohei Mishima more than expected).
Fields of papers citing papers by Shohei Mishima
This network shows the impact of papers produced by Shohei Mishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shohei Mishima. The network helps show where Shohei Mishima may publish in the future.
Co-authorship network of co-authors of Shohei Mishima
This figure shows the co-authorship network connecting the top 25 collaborators of Shohei Mishima. A scholar is included among the top collaborators of Shohei Mishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shohei Mishima. Shohei Mishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 12 | |
| 7 | 33 | |
| 8 | 28 | |
| 9 | 21 | |
| 10 | 76 | |
| 11 | 122 | |
| 12 | 25 | |
| 13 | [Effects of topical indomethacin on suppression of inflammation after the ocular surgeries--double masked study of anti-inflammatory effects on the intra capsular lens extraction]. | 3 |
About Shohei Mishima
Shohei Mishima is a scholar working on Endocrine and Autonomic Systems, Clinical Biochemistry and Pharmacology, having authored 13 papers that have together received 333 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (4 papers), Sleep and Wakefulness Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Neurology (106 citations), Clinical Biochemistry (51 citations) and Pharmacology (114 citations). Shohei Mishima has collaborated with scholars based in Japan, Austria and United States. Frequent co-authors include Michihiro Fujiwara, Kazuhide Hayakawa, Kenichi Mishima, Katsunori Iwasaki, Nobuaki Egashira, Mai Hazekawa, Kensuke Orito, Masayuki Fujioka, Masanori Nozako and Keiichi Irie. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.